1992
DOI: 10.1212/wnl.42.2.462
|View full text |Cite
|
Sign up to set email alerts
|

Brachial plexopathy associated with interleukin‐2 therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

1999
1999
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 0 publications
1
19
0
Order By: Relevance
“…A postmortem based study showed widespread demyelination 43. A focal immune mediated mechanism of demyelination has been postulated in interleukin-2 associated brachial plexopathy 44. Immune complex formation has also been implicated as a cause of acute brachial plexus neuropathy and the Guillain-Barré syndrome associated with serum sickness 45.…”
Section: Discussionmentioning
confidence: 99%
“…A postmortem based study showed widespread demyelination 43. A focal immune mediated mechanism of demyelination has been postulated in interleukin-2 associated brachial plexopathy 44. Immune complex formation has also been implicated as a cause of acute brachial plexus neuropathy and the Guillain-Barré syndrome associated with serum sickness 45.…”
Section: Discussionmentioning
confidence: 99%
“…Association has been described with preceeding viral infections or vaccination (especially tetanus) 4,5 and with the use of immunomodulating agents such as interleukin-2 (IL-2) and interferon therapy. 6,7 Histological studies of the affected nerves of six patients demonstrate T lymphocyte-predominant chronic inflammatory infiltrates with lymphoid germinal centres and onion-bulb formation. 3,8 It has been proposed that cell-mediated immune demyelination, similar to that seen when leuco-encephalopathy develops as a complication of IL-2 therapy, may be the mechanism.…”
Section: Discussionmentioning
confidence: 97%
“…Association has been described with preceeding viral infections or vaccination (especially tetanus) 4,5 and with the use of immunomodulating agents such as interleukin‐2 (IL‐2) and interferon therapy. 6,7 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Painful brachial plexopathy has been described (Loh et al, 1992), similar to the case of neuralgic amyotrophy caused by interferon treatment, as described by Bernsen et al (1988). Painful brachial plexopathy has been described (Loh et al, 1992), similar to the case of neuralgic amyotrophy caused by interferon treatment, as described by Bernsen et al (1988).…”
Section: Interleukin-2mentioning
confidence: 89%